Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Marta Barisella"'
Autor:
Jean-Yves Blay, Domenico Franco Merlo, Claudia Valverde, Antonella Brunello, Paola Collini, Salvatore Lorenzo Renne, Cleofé Romagosa, Antonio Lopez-Pousa, Joaquín Dopazo, Silvia Stacchiotti, Piero Picci, Angelo Paolo Dei Tos, Marco Gambarotti, Marta Barisella, Rafael Ramos, Paolo G. Casali, Antonio Gutierrez, Valérie Velasco, J. Martin-Broto, Silvia Bagué, David S. Moura, Nadia Hindi, Vittorio Quagliuolo, Giovanni Grignani, Maria Lopez-Alvarez, Alessandro Gronchi, Jean-Michel Coindre, Daniel Lopez-Lopez, Emanuela Palmerini, Luca Braglia
Publikováno v:
MOLECULAR CANCER THERAPEUTICS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Digital.CSIC. Repositorio Institucional del CSIC
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Digital.CSIC. Repositorio Institucional del CSIC
MRP-1 is implicated in multidrug resistance and was described as prognostic in high-risk patients with soft-tissue sarcoma (STS) in a previous study. The current research aimed to validate MRP-1 prognostic/predictive value in localized sarcomas treat
Autor:
Noemi Simeone, Marta Sbaraglia, Annarita Palomba, Sandro Pasquali, Filippo Frenos, Dario Callegaro, Luigi Mariani, Giacomo Giulio Baldi, Marta Barisella, Silvia Stacchiotti, Angelo Paolo Dei Tos, Alessandro Gronchi, Marco Gambarotti, Domenico Andrea Campanacci, Anna Maria Frezza, Paolo G. Casali, Salvatore Lo Vullo
Publikováno v:
European Journal of Surgical Oncology. 46:1320-1326
Introduction This case-series is aimed to describe the natural history of epithelioid sarcoma (ES) and to provide insights into the differential clinical behaviour of its two variants (“classic-type” and “proximal-type”). The value of a subty
Autor:
Marco Fiore, Silvia Stacchiotti, Anna Maria Frezza, Marta Barisella, Stefano Radaelli, Alberto Righi, Anna Paioli, Giovanni Beltrami, Giuseppe Bianchi, Emanuela Palmerini, Piero Picci, Domenico Andrea Campanacci, Alessandro Gronchi, Stefania Benini, Alessandra Longhi, Davide Maria Donati
Publikováno v:
Annals of Surgical Oncology. 28:1142-1150
Background: Extraskeletal myxoid chondrosarcoma (EMC) is a rare sarcoma of uncertain origin, marked by specific chromosomal translocations involving the NR4A3 gene, and usually characterized by an indolent course. Surgery (with or without radiotherap
Autor:
Dong Hum Yoon, Marco Fiore, William W. Tseng, Marta Barisella, Stefano Radaelli, Francesco Barretta, Dario Callegaro, Alessandro Gronchi, Marco Baia
Publikováno v:
Journal of surgical oncologyREFERENCES. 124(5)
BACKGROUND In extremity or trunk liposarcoma, the implications of a dedifferentiated (DD) component within a well-differentiated (WD) tumor are unclear. We evaluated outcomes after surgery and identified potential predictors of survival in these pati
Autor:
Roberta Sanfilippo, Angelo Paolo Dei Tos, Carlo Morosi, Alessandro Gronchi, Paolo G. Casali, Elena Fumagalli, Chiara Fabbroni, Marta Barisella, Giovanni Fucà, Francesca Ligorio, Paola Collini
Publikováno v:
Cancers
Cancers, Vol 13, Iss 1453, p 1453 (2021)
Volume 13
Issue 6
Cancers, Vol 13, Iss 1453, p 1453 (2021)
Volume 13
Issue 6
Background. We previously showed that grading can prognosticate the outcome of retroperitoneal liposarcoma (LPS). In the present study, we aimed to explore the impact of pathological stratification using grading on the clinical outcomes of patients w
Autor:
Alexandra Meurgey, Paolo G. Casali, Katherine Thornton, Scott M. Schuetze, Maria Abbondanza Pantaleo, Jean-Yves Blay, Marta Sbaraglia, Salvatore Lo Vullo, Tarek Assi, Paweł Teterycz, Robert G. Maki, Hans Gelderblom, Anna Maria Frezza, Robin L. Jones, Jason L. Hornick, Olivier Mir, Eytan Ben-Ami, Silvia Stacchiotti, Axel Le Cesne, Vinod Ravi, Luigi Mariani, Ingrid M.E. Desar, Alexander Fedenko, Anna M. Czarnecka, Florence Duffaud, Andrew J. Wagner, Richard Ferraro, Akira Kawai, Emi Noguchi, Brittany Siontis, Robert S. Benjamin, Bruno Vincenzi, Alessandro Gronchi, Giacomo Giulio Baldi, Mrinal M. Gounder, Armelle Dufresne, Julien Adam, Kan Yonemori, Marta Barisella
Publikováno v:
Cancer, 126, 1, pp. 98-104
Cancer, 126, 98-104
Cancer
Cancer. WILEY
Cancer, 126, 98-104
Cancer
Cancer. WILEY
Contains fulltext : 220839.pdf (Publisher’s version ) (Closed access) BACKGROUND: Intimal sarcoma (InS) is an exceedingly rare neoplasm with an unfavorable prognosis, for which new potentially active treatments are under development. We report on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be658f0d6087906fb37344e619ca0e8
https://hdl.handle.net/2066/220839
https://hdl.handle.net/2066/220839
Autor:
Alessandro Gronchi, Antonio Lopez-Pousa, Jean-Yves Blay, Silvia Stacchiotti, Emanuela Palmerini, Sandro Pasquali, Domenico Franco Merlo, Cleofé Romagosa, Vittorio Quagliuolo, Paolo G. Casali, Paolo De Tos, Silvia Bagué, Paola Collini, Jean Michel Coindre, Marta Barisella, Giovanni Grignani, Javier Martin Broto, Robert Diaz Beveridge, Chiara Castelli, Luca Braglia
Publikováno v:
Journal of Clinical Oncology. 39:11572-11572
11572 Background: The characteristics of immune contexture and its prognostic and predictive value in STS is left to be understood. This planned analysis of the ISG-STS-1001 trial, which compared neoadjuvant anthracycline + ifosfamide (AI) vs a histo
Autor:
Carlo Morosi, Stefano Radaelli, Chiara Colombo, Fabio Tirotta, Paolo G. Casali, Alessandro Gronchi, Elena Fumagalli, Marta Barisella, A.M. Frezza, Marco Fiore
Publikováno v:
Journal of Surgical Oncology.
Background The aim was to describe complicated tumor response (CTR) to tyrosine-kinase inhibitors (TKI) in gastrointestinal stromal tumors (GIST) patients. Methods From 2001 to 2017, data from patients with metastatic (group A) or locally advanced (g
Autor:
Paola Collini, Paolo G. Casali, Marta Barisella, Luigi Mariani, Carlo Morosi, G.P. Dagrada, Silvia Stacchiotti, Alessandro Gronchi, Nadia Zaffaroni, S. Lo Vullo, A.M. Frezza, Francesca Greco, Noemi Simeone
Publikováno v:
European journal of cancer (Oxford, England : 1990). 106
Background To explore the activity of axitinib in advanced solitary fibrous tumour (SFT). Patients and methods In this investigator-driven phase II study on axitinib in advanced and progressive SFT, patients received axitinib, 5 mg bis in day (BID),
Publikováno v:
The Lancet Diabetes & Endocrinology. 8:868